
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
With non-invasive positive pressure ventilation, oxygen is delivered to the lungs through positive pressure without the use of an endotracheal tube.
It is used in both acute and chronic respiratory failure, but to be effective and prevent problems, it needs to be closely monitored and titrated.
There are several different NIV modes that are available, including nasal cannula, simple mask, non rebreather, high flow nasal cannula, continuous positive airway pressure (CPAP), and bilevel positive airway pressure.
NIV stands for non-invasive ventilation, which is the provision of respiratory assistance. By doing this, some of the problems associated with invasive ventilation are avoided, including the necessity for sedation and the associated dangers of haemodynamic instability and delirium, nosocomial infection, etc.
The Global Noninvasive Positive Pressure Breathing Machine Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
An increasingly popular method for providing mechanical breathing in both acute and chronic diseases is noninvasive positive pressure ventilation (NPPV).
The evidence for using NPPV in acute respiratory failure (ARF) caused by various diseases is examined in the current review.
The use of NPPV for ARF to prevent endotracheal intubation (ETI), facilitate extubation in patients with acute exacerbations of chronic obstructive pulmonary disease, avoid ETI in patients with acute cardiogenic pulmonary oedema, and in patients with compromised immune systems is supported by a strong body of research.
Acute respiratory failure is increasingly being managed using noninvasive positive pressure ventilation, but carers must adhere to indications that are backed by evidence and avoid contraindications. In order to avoid unsatisfactory results, the procedure must be used by a skilled team in the proper place.
While assuring a similar level of performance, noninvasive mechanical ventilation may prevent the majority of these issues. Noninvasive ventilation preserves airway defence systems, which reduces the risk of nosocomial infections such as ventilation-acquired pneumonia (VAP) and other nosocomial infections.
When compared to invasive mechanical ventilation, this technique improves patient comfort by enabling them to eat, drink, cough, and communicate while avoiding or minimising the need for sedation and doing so without increasing costs or the strain of the nurses.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |